JOHN COLEMAN: Open Payments
NPI 1063945475 · FOREST, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 18 payments from 6 companies in 2025. Trend: 2023 $516 · 2024 $440 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $146 |
| AstraZeneca Pharmaceuticals LP | 8 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| ABBVIE INC. | 1 | $22 |
| Abbott Laboratories | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: Ozempic, AIRSUPRA, CAPLYTA, FARXIGA, VRAYLAR, FREESTYLE LIBRE 3, REXULTI.
Industry payments across MS — which companies pay providers there.
